Glecirasib
Product Specifications
CAS Number
2657613-87-9
Synonyms
JAB-21822, KRAS G12C inhibitor 36
Target
Ras
Applications
Apoptosis
Molecular Formula
C31H26ClF4N7O2
Additionnal Information
Glecirasib (JAB-21822, KRAS G12C inhibitor 36) is a potent, and highly selective, covalent inhibitor of KRAS G12C. It exhibits promising anti-tumor activity in KRAS G12C-mutated pancreatic ductal adenocarcinoma (PDAC), Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) and other solid tumors.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
169758 50 µg
Tgfbr2, Control Peptide (TGF-beta Receptor Type-2, TGFR-2, TGF-beta Type II Receptor, Transforming Growth Factor-beta Receptor Type II, TGF-beta Receptor Type II, TbetaR-II) discontinued
Sign In for Pricing
View Details